TRIOMUNE

Triomune Adverse Events Reported to the FDA Over Time

How are Triomune adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Triomune, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Triomune is flagged as the suspect drug causing the adverse event.

Most Common Triomune Adverse Events Reported to the FDA

What are the most common Triomune adverse events reported to the FDA?

Death	37 (5.48%)
Immune Reconstitution Syndrome	35 (5.19%)
Neuropathy Peripheral	32 (4.74%)
Weight Decreased	27 (4%)
Hyperlactacidaemia	26 (3.85%)
Vomiting	24 (3.56%)
Tuberculosis	20 (2.96%)
Drug Resistance	18 (2.67%)
Drug Ineffective	15 (2.22%)
Rash	15 (2.22%)
Abdominal Discomfort	14 (2.07%)
	Show More
Drug Effect Decreased	13 (1.93%)
Anorexia	12 (1.78%)
Hepatotoxicity	12 (1.78%)
Meningitis Cryptococcal	12 (1.78%)
Anaemia	9 (1.33%)
Diarrhoea	9 (1.33%)
Lactic Acidosis	9 (1.33%)
Nausea	9 (1.33%)
Fatigue	8 (1.19%)
Hepatic Steatosis	8 (1.19%)
Hepatitis	8 (1.19%)
Lipoatrophy	8 (1.19%)
Pulmonary Tuberculosis	8 (1.19%)
Viral Mutation Identified	8 (1.19%)
Pyrexia	7 (1.04%)
Stevens-johnson Syndrome	7 (1.04%)
Adverse Event	6 (.89%)
Mycobacterial Infection	6 (.89%)
Opportunistic Infection	6 (.89%)
Drug Exposure During Pregnancy	5 (.74%)
Headache	5 (.74%)
Jaundice	5 (.74%)
Sepsis	5 (.74%)
Toxic Epidermal Necrolysis	5 (.74%)
Asthenia	4 (.59%)
Central Nervous System Lymphoma	4 (.59%)
Cerebral Toxoplasmosis	4 (.59%)
Cytomegalovirus Chorioretinitis	4 (.59%)
Decreased Appetite	4 (.59%)
Hemiparesis	4 (.59%)
Ischaemic Stroke	4 (.59%)
Mitochondrial Toxicity	4 (.59%)
Mycobacterium Avium Complex Infecti...	4 (.59%)
Pneumonia	4 (.59%)
Progressive Multifocal Leukoencepha...	4 (.59%)
Pruritus	4 (.59%)
Rash Maculo-papular	4 (.59%)
Abdominal Pain	3 (.44%)
Aids Related Complication	3 (.44%)
Alanine Aminotransferase Increased	3 (.44%)
Ascites	3 (.44%)
Cerebrovascular Accident	3 (.44%)
Confusional State	3 (.44%)
Disease Recurrence	3 (.44%)
Dyspnoea	3 (.44%)
Hepatic Failure	3 (.44%)
Hypersensitivity	3 (.44%)
Pancytopenia	3 (.44%)
Pneumocystis Jiroveci Pneumonia	3 (.44%)
Abdominal Distension	2 (.3%)
Abscess	2 (.3%)
Bacterial Sepsis	2 (.3%)
Cerebral Haematoma	2 (.3%)
Cognitive Disorder	2 (.3%)
Cough	2 (.3%)
Cytomegalovirus Infection	2 (.3%)
Disseminated Tuberculosis	2 (.3%)
Drug Hypersensitivity	2 (.3%)
End Stage Aids	2 (.3%)
Gastroenteritis	2 (.3%)
Herpes Zoster	2 (.3%)
Hypertension	2 (.3%)
Insomnia	2 (.3%)
Lacunar Infarction	2 (.3%)
Lobar Pneumonia	2 (.3%)
Malaria	2 (.3%)
Monoplegia	2 (.3%)
Nail Discolouration	2 (.3%)
Neutropenia	2 (.3%)
Oral Candidiasis	2 (.3%)
Pain	2 (.3%)
Palpitations	2 (.3%)
Paraesthesia	2 (.3%)
Pathogen Resistance	2 (.3%)
Respiratory Disorder	2 (.3%)
Respiratory Distress	2 (.3%)
Spinal Cord Compression	2 (.3%)
Subarachnoid Haemorrhage	2 (.3%)
Urticaria	2 (.3%)
Viral Load Increased	2 (.3%)
Acquired Immunodeficiency Syndrome	1 (.15%)
Anal Fistula	1 (.15%)
Anxiety	1 (.15%)
Aphonia	1 (.15%)
Aplasia Pure Red Cell	1 (.15%)
Auricular Swelling	1 (.15%)
Blepharospasm	1 (.15%)
Body Temperature Increased	1 (.15%)
Cachexia	1 (.15%)
Cholera	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Triomune, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triomune is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Triomune

What are the most common Triomune adverse events reported to the FDA?

Therapeutic And Nontherapeutic Effe...	55 (8.15%)
Gastrointestinal Signs	52 (7.7%)
Mycobacterial Infectious	43 (6.37%)
Epidermal And Dermal Conditions	39 (5.78%)
Fatal Outcomes	38 (5.63%)
Hepatic And Hepatobiliary	38 (5.63%)
Immunodeficiency Syndromes	36 (5.33%)
Acid-base	35 (5.19%)
Peripheral Neuropathies	32 (4.74%)
Infections - Pathogen Unspecified	30 (4.44%)
Physical Examination Topics	28 (4.15%)
	Show More
Viral Infectious	22 (3.26%)
Fungal Infectious	21 (3.11%)
Appetite And General Nutritional	17 (2.52%)
Anemias Nonhemolytic And Marrow Dep...	13 (1.93%)
Central Nervous System Vascular	13 (1.93%)
Microbiology And Serology	11 (1.63%)
Gastrointestinal Motility And Defec...	9 (1.33%)
Respiratory	9 (1.33%)
Skin And Subcutaneous Tissue	9 (1.33%)
Neurological	8 (1.19%)
Bacterial Infectious	7 (1.04%)
Body Temperature Conditions	7 (1.04%)
Movement Disorders	7 (1.04%)
Protozoal Infectious	7 (1.04%)
Allergic Conditions	5 (.74%)
Chemical Injury And Poisoning	5 (.74%)
Headaches	5 (.74%)
Hepatobiliary	4 (.59%)
Lymphomas	4 (.59%)
Metabolism	4 (.59%)
Deliria	3 (.44%)
Peritoneal And Retroperitoneal Cond...	3 (.44%)
Angiedema And Urticaria	2 (.3%)
Cardiac Disorder Signs	2 (.3%)
Mental Impairment	2 (.3%)
Skin Appendage Conditions	2 (.3%)
Sleep Disorders	2 (.3%)
Spinal Cord And Nerve Root	2 (.3%)
Vascular Hypertensive	2 (.3%)
White Blood Cell	2 (.3%)
Anxiety Disorders	1 (.15%)
Central Nervous System Infections A...	1 (.15%)
Depressed Mood Disorders	1 (.15%)
Electrolyte And Fluid Balance Condi...	1 (.15%)
Exocrine Pancreas Conditions	1 (.15%)
External Ear Disorders	1 (.15%)
Gastrointestinal Conditions	1 (.15%)
Glucose Metabolism Disorders	1 (.15%)
Lipid Metabolism	1 (.15%)
Lower Respiratory Tract Disorders	1 (.15%)
Musculoskeletal And Connective Tiss...	1 (.15%)
Musculoskeletal And Connective Tiss...	1 (.15%)
Myocardial	1 (.15%)
Ocular Neuromuscular	1 (.15%)
Pericardial	1 (.15%)
Platelet	1 (.15%)
Red Blood Cell	1 (.15%)
Renal Disorders	1 (.15%)
Reproductive Tract	1 (.15%)
Seizures	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Triomune, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triomune is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.